Patents (1436 Stem Cell Patents)

Class: Expansion (424)

Order by:
<< | < | 1 2 3 4 5 6 7 8 9 | > | >>


Telomerase reverse transcriptase fragments and uses thereof

Patent Number: 7,294,708

Telomerase reverse transcriptase is an enzyme that transcribes the telomerase RNA component into telomeric DNA in order to replenish telomeric loss associated with cellular proliferation. The activity of telomerase is absent in most adult cells with the exception of stem cells and tumor cells. Accordingly, one possible method of blocking tumor...

Inventors: Huang; Jun Jian (Beijing, CN), Huang; Cui-Fen (Beijing, CN), Lin; Marie C. M. (Hong Kong, CN), Kung; Hsiang-Fu (Hong Kong, CN)
Assignee: Beijing Institute of Biotechnology (Beijing, CN); The University of Hong Kong (Hong Kong, CN)
Date of First Priority Issue: Friday May 31st, 2002

Compositions and treatments for myelosuppression by ex vivo activated immune cells

Patent Number: 7,332,158

Failure/suppression of the hematopoietic can be a deadly consequence of over-aggressive administration of chemotherapeutics/radiotherapy. The global market for agents that stimulate hematopoiesis, particularly granulopoiesis is in the billions of dollars per year, as witnessed by the success of Amgen’s Neuopgen and Neulasta products. The current patent teaches a novel, and arguably more...

Inventors: Yang; Demao (Mountain View, CA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Wednesday May 29th, 2002

Stimulation of hematopoiesis by ex vivo activated immune cells

Patent Number: 7048922

This patent covers a clinically applicable method of increasing hematopoiesis through administration of activated peripheral blood mononuclear cells. The ability of these cells to secrete hematopoietic stimulatory cytokines is well established, however the inventor is actually claiming a method of using such ex vivo activated cells for treatment of a patient. The patent has 1 independent...

Inventor: Yang, Demao (Mountain View, CA)
Assignee: Unknown Assignee(s)
Date of First Priority Issue: Wednesday May 29th, 2002

Spinal fusion using an HMG-CoA reductase inhibitor

Patent Number: 7041309

HMG-CoA reductase inhibitors ("Statins" for the purpose of our discussion) have been known to increase endothelial stem cell mobilization, as well as possess other interesting functions such as suppressing disease in the mouse model of multiple sclerosis. In this patent, the use of statins for promoting spinal fusion is thought. Specifically, the patent...

Inventors: Remington, Benjamin J. (Modesto, CA); Bearss, David J. (Tucson, AZ); Shahi, Kavian (Granite Bay, CA)
Assignee: NeuroPro Technologies, Inc. (Modesto, CA)
Date of First Priority Issue: Monday May 13th, 2002

Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells

Patent Number: 7,439,332

This patent covers a specific nucleic acid sequence and expressed protein thereof, for the stimulation of erythropoiesis. 

The inventors identified the protein through establishing stromal cell lines from the AGM (Aorta-Gonad-Mesonephros) region of a fetal mouse and screening them to see which ones support hematopoiesis, and which type of hematopoietic propensity (eg were they...

Inventors: Nishikawa; Mitsuo (Gunma, JP)
Assignee: Kirin Pharma Kabushiki Kaisha (Tokyo-To, JP)
Date of First Priority Issue: Friday April 26th, 2002

Method of stimulating stem cells

Patent Number: 7,524,500

Methods of expanding stem cells are well-known in the art.  For example, #7,423,029 teaches the use of heterocyclic trialkyl ammonium-containing compounds for stimulation of bone marrow stem cells.  #7,135,459 covers use of FGF homologues for expansion of neural and chondrocytic stem cells.  # Inventors: Mueller; Susan (Milton, CA), Bell; David (Oakville, CA), Matthews; Kathryn Emma (Toronto, CA)

Assignee: Therapure Biopharma Inc. (Mississauga, Ontario, CA)
Date of First Priority Issue: Tuesday March 26th, 2002

Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby

Patent Number: 7,344,881

This patent covers methods of expanding hematopoietic stem cells and their progenitors. The methods induce expansion but not differentiation of the cells. Essentially the patent teachs that expansion can be achieved by culture in media containing an "effective amount of TEPA-Cu chelate". TEPA stands for tetraethylenepentamine...

Inventors: Peled; Tony (Mevaseret Zion, IL), Treves; Avi (Mevaseret Zion, IL), Rosen; Oren (Jerusalem, IL)
Assignee: Gamida Cell Ltd. (Jerusalem, IL)
Date of First Priority Issue: Friday January 25th, 2002

Serum-free media for chondrocytes and methods of use thereof

Patent Number: 7,169,610

This patent discloses methods of expanding chondrocyte precursors and differentiated chondrocytes ex vivo without the use of animal derived tissue culture components. The patent teaches the use of growth factors such as platelet derived growth factor, together with specific lipids, such as stearic acid, myristic acid, oleic acid, linoleic acid, palmitic acid, palmitoleic acid...

Inventors: Brown; Liesbeth Maria E. (West Newton, MA)
Assignee: Genzyme Corporation (Cambridge, MA)
Date of First Priority Issue: Friday January 25th, 2002

Cytokine zcytor17 ligand

Patent Number: 7064186

This is a composition of matter patent covering the cytokine zcytor17 ligand, which is involved in various immune and stem cell activities. The patent has 3 independent claims, all covering composition of matter. The email of the senior author is dillons@zgi.com

Inventors: Sprecher, Cindy A. (Sierra Vista, AZ); Kuijper, Joseph L. (Kenmore, WA); Dasovich, Maria M. (Seattle, WA); Grant, Francis J. (Seattle, WA); Hammond, Angela K. (Kirkland, WA); Novak, Julia E. (Suquamish, WA); Gross, Jane A. (Seattle, WA); Dillon, Stacey R.
Assignee: ZymoGenetics, Inc. (Seattle, WA)
Date of First Priority Issue: Friday January 18th, 2002

Human hematopoietic growth regulatory gene and uses

Patent Number: 6900017

HIWI is the human homologue of PIWI a gene found in fruitfly embryonic germline stem cells. HIWI is found in CD34 hematopoietic cells and appears to act as a negative regulator in that its transfection causes apoptosis in hematopoietic cell lines (Sharma AK...

Inventors: Sharma, Arun (Oak Park, IL); Hoffman, Ronald (Chicago, IL)
Assignee: The Board of Trustees of the University of Illinois (Urbana, IL)
Date of First Priority Issue: Thursday January 10th, 2002

Order by:
<< | < | 1 2 3 4 5 6 7 8 9 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent